514
Participants
Start Date
January 31, 2004
Primary Completion Date
April 30, 2009
Study Completion Date
February 29, 2012
Fulvestrant
intramuscular injection 250 mg loading dose (LD) regimen
Anastrozole
1 mg oral tablet
Research Site, Brampton
Research Site, Halifax
Research Site, Kingston
Research Site, Ontario
Research Site, Toronto
Research Site, San José
Research Site, Hämeenlinna
Research Site, Turku
Research Site, Avignon
Research Site, Caen
Research Site, Créteil
Research Site, Grenoble
Research Site, La Chaussée-Saint-Victor
Research Site, Perpignan
Research Site, Périgueux
Research Site, Saint Cyr Sur Louire
Research Site, Toulouse
Research Site, Augsburg
Research Site, Cologne
Research Site, Düsseldorf
Research Site, Erlangen
Research Site, Frankfurt
Research Site, Gifhorn
Research Site, Großhadern
Research Site, Halle
Research Site, Hamburg
Research Site, Hanover
Research Site, Heidelberg
Research Site, Ingolstadt
Research Site, Kassel
Research Site, Kiel
Research Site, Leipzig
Research Site, Leverkusen
Research Site, Magdeburg
Research Site, Mannheim
Research Site, Marburg
Research Site, München
Research Site, Rostock
Research Site, Trier
Research Site, Ulm
Research Site, Ziwicken
Research Site, Guatemala City
Research Site, Reykjavik
Research Site, Como
Research Site, Fabriano
Research Site, Ferrara
Research Site, Florence
Research Site, Lugo
Research Site, Milan
Research Site, Taormina
Research Site, Treviglio
Research Site, Vicenza
Research Site, Drammen
Research Site, Ilesund
Research Site, Oslo
Research Site, Porsgrunn
Research Site, Stavanger
Research Site, Troms
Research Site, Trondheim
Research Site, Cascais
Research Site, Coimbra
Research Site, Lisbon
Research Site, Santa Maria da Feira
Research Site, Halmstad
Research Site, Helsingborg
Research Site, Kalmar
Research Site, Karlskrona
Research Site, Kristianstad
Research Site, Link'ping
Research Site, M'lndal
Research Site, Malm
Research Site, Norrk'ping
Research Site, Skellefteå
Research Site, Skövde
Research Site, Södra Sunderbyn
Research Site, Stockholm
Research Site, Sundsvall
Research Site, Umeå
Research Site, V'rnamo
Research Site, V'stervik
Research Site, Varberg
Research Site, Ankara
Research Site, Edirne
Research Site, Gaziantep
Research Site, Istanbul
Lead Sponsor
AstraZeneca
INDUSTRY